| JYSB2100068 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2021-03-10 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2021-03-10 | view |
| JYSB2100067 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2021-03-10 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2021-03-10 | view |
| JYSB2100066 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2021-03-10 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2021-03-10 | view |
| JTH2100025 | 利司那肽 | lixisenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2021-01-26 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2021-02-05 | view |
| JTH2100024 | 利司那肽（高分子蛋白系统适用性标准品） | lixisenatide | Other | Chemical Drugs | Disposable Import Drug Application | 2021-01-26 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2021-02-05 | view |
| JTH2000218 | 环酰亚胺-Asn (28)-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2020-07-29 | view |
| JTH2000213 | Des-[His(1)-Asp(9)]-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | In Review | 2020-07-29 | view |
| JTS2000033 | 甘精胰岛素 | insulin glargine | Injection | Biological Products | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2020-08-24 | view |
| JTH2000217 | 环酰亚胺-Asp(9)-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2020-08-25 | view |
| JTS2000032 | OA-Arg-甘精胰岛素 | | Active ingredient | Biological Products | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Approval Completed-Pending Certificated | 2020-08-24 | view |
| JTH2000216 | Iso-Asp(9)- 利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2020-08-25 | view |
| JTH2000220 | 利司那肽 | lixisenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2020-08-25 | view |
| JTH2000215 | L-iso-Asp(28)-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2020-08-25 | view |
| JTH2000219 | 利司那肽 | lixisenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2020-08-25 | view |
| JTH2000214 | Des-[His(1)-Gly(2)]-利司那肽 | | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-08-06 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2020-08-25 | view |
| JYSB2000324 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2020-06-29 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Filed | 2020-07-01 | view |
| JYSB2000323 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2020-06-29 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Filed | 2020-07-01 | view |
| JYSB2000322 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2020-06-29 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Filed | 2020-07-01 | view |
| JYSF1900021 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2019-12-03 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2019-12-19 | view |
| JYSB1900331 | 谷赖胰岛素注射液 | insulin glulisine | Injection | Biological Products | Supplementary Application | 2019-11-26 | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis Deutschland GmbH | Filed | 2019-12-10 | view |
